StockWatch
·
Misc Health and Biotechnology Services
InvestmentJun 22, 2026, 09:47 AM

NewGenIvf Issues 3.67M Shares; Market Cap Reaches $7.6M After K25.ai Deal

AI Summary

NewGenIvf Group Ltd announced the issuance of 3,666,667 new shares, bringing its total outstanding shares to 10,073,535. This action, linked to its strategic acquisition of a 10% equity interest in K25.ai, helped the company reach a market capitalization of US$7,631,710 as of June 18, 2026. The company also made a subsequent US$10 million investment in K25.ai, reinforcing its strategic pivot towards AI and digital platforms and positioning it to meet Nasdaq's minimum market value requirements.

Key Highlights

  • Issued 3,666,667 new shares in connection with the K25.ai acquisition.
  • Total outstanding shares now stand at 10,073,535.
  • Market capitalization reached US$7,631,710 on June 18, 2026.
  • Net asset value was approximately US$25.98 million as of December 31, 2025.
  • Strengthened balance sheet with a subsequent US$10 million investment in K25.ai.
  • Acquired a 10% equity interest in K25.ai, an AI-powered live-streaming prediction platform.
  • Believes it is well-positioned to meet Nasdaq's proposed US$5 million MVLS threshold.